Autism spectrum disorders.
Conditions
Interventions
Intramuscular Cerebrolysin injection
1cc in 3 days a week in first month of study, followed by gradual decrease in dose during the second month ( two injections in first week, two injection in second
Treatment - Drugs
Intramuscular Cerebrolysin injection
1cc in 3 days a week in first month of study, followed by gradual decrease in dose during the second month ( two injections in first week, two injection in secon
Sponsors
Vice chancellor for research,Tehran University of Medical Sciences
Vice chancellor for research,Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
3 Years to 10 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria:All 3 to 10 year-old children suffering from Autism spectrum disorder referred to pediatric neurologic clinic in pediatric center of excellence from August 2014 to February 2015 are included in this study. Exclusion criteria: receive of any kinds of new medications during the recent three months ago; past history of uncontroled seizure; past history of intra-cerebral hemorrhage.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Verbal and Non-verbal Communication,Emotional response,relationship to people. Timepoint: Three Months. Method of measurement: Childhood Autism Rating Scale Test. | — |
Secondary
| Measure | Time frame |
|---|---|
| -. Timepoint: -. Method of measurement: -. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Vafaee-Shahi
Tehran University of Medical Science
Outcome results
None listed